Preservation of Venous Valvular Function After PMT for Acute DVT

NCT05588284 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-05-05

No results posted yet for this study

Summary

To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.

Conditions

  • Acute Deep Venous Thrombosis of Femoral Vein (Disorder)

Interventions

DEVICE

AngioJet device

A device can be used for thrombus aspiration and thrombolysis.

OTHER

anticoagulation alone

a medicine for anticoagulation therapy

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY
  • Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    lead OTHER

Principal Investigators

  • Kaichuang Ye, MD, PhD · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-06
Primary Completion
2026-12-30
Completion
2026-12-30
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05588284 on ClinicalTrials.gov